Coronary Intervention in Patients With Acute Coronary Syndrome: Does Every Culprit Lesion Require Revascularization?
- First Online:
- 76 Downloads
In patients presenting with acute coronary syndromes, 30–60% of patients have multiple significant coronary lesions. Patients presenting with acute coronary syndrome and multivessel disease have a significant increase in the incidence of major cardiovascular morbidity and mortality when compared with patients who have single-vessel disease. Although great progress has been made to reduce the extent of infarction through effective and rapid reperfusion due to faster time to reperfusion, potent antiplatelets, and antithrombotics, there is not much consensus as to how best to treat multivessel disease in patients presenting with acute coronary syndromes. We present a review of the current body of evidence for safety and efficacy of multivessel revascularization in patients presenting with acute coronary syndromes.
KeywordsCulprit lesion angioplasty Acute coronary syndromes Complete revascularization
Clinical Trial Acronyms
Bypass Angioplasty Revascularization Investigation
Coronary Artery Surgery Study
- FUTURA/OASIS 8
Fondaparinux Trial With UFH During Revascularization in Acute Coronary Syndromes
- HELP AMI
Hepacoat for Culprit or Multivessel Stenting for Acute Myocardial Infarction
Providing Regional Observations to Study Predictors of Events in the Coronary Tree
Thrombolysis and Angioplasty in Myocardial Infarction
- TACTICS-TIMI 18
Treat Angina With Aggrastat and Determine Cost of Therapy With an Invasive or Conservative Strategy